Home » Topics » Conferences

Conferences
RSS

Oral toxicity of SarCNU in rats

May 13, 1997

Preclinical and preliminary clinical studies on flavopiridol

May 13, 1997

Preclinical characterization of aplidine

May 13, 1997

Prevention of breast cancer with Targretin

May 13, 1997

Menarini prepares new NNRTIs with potent anti-HIV activity

May 13, 1997

Orally active FdUrd derivative prepared at Taiho

May 13, 1997

Pfizer and Oncogene characterize EGF receptor TK inhibitor

May 13, 1997

Preliminary clinical results for LMB-2

May 13, 1997

Trimidox enhances effects of doxorubicin in vivo

May 13, 1997

Dual 5alpha-reductase type I/II inhibitor from Lilly for prostatic cancer

May 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...